127 related articles for article (PubMed ID: 20450746)
1. [Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):235-41. PubMed ID: 20450746
[TBL] [Abstract][Full Text] [Related]
2. [Association of genetic polymorphisms and haplotypes in hMLH1 and hMSH3 gene with the risk of papillary thyroid carcinoma].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):390-5. PubMed ID: 18683134
[TBL] [Abstract][Full Text] [Related]
3. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma].
Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397
[TBL] [Abstract][Full Text] [Related]
5. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
[TBL] [Abstract][Full Text] [Related]
6. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
[TBL] [Abstract][Full Text] [Related]
7. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
8. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.
Jha R; Gaur P; Sharma SC; Das SN
Gene; 2013 Sep; 526(2):223-7. PubMed ID: 23727610
[TBL] [Abstract][Full Text] [Related]
10. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
11. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
13. miR-146a rs2910164 Polymorphism and Risk of Papillary Thyroid Carcinoma: A Meta-Analysis.
Chen H; Zhang H; Liu Y; Chen Z; Gu J; Cui D; Yang T
Genet Test Mol Biomarkers; 2018 Dec; 22(12):674-679. PubMed ID: 30484703
[No Abstract] [Full Text] [Related]
14. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
15. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
Zhu J; Qi P; Li Z
Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer.
Guan H; Ji M; Hou P; Liu Z; Wang C; Shan Z; Teng W; Xing M
Cancer; 2008 Jul; 113(2):247-55. PubMed ID: 18470905
[TBL] [Abstract][Full Text] [Related]
17. Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies.
Zare M; Jafari-Nedooshan J; Jafari M; Neamatzadeh H; Abolbaghaei SM; Foroughi E; Nasiri R; Zare-Shehneh M
Rev Assoc Med Bras (1992); 2018 Oct; 64(10):942-951. PubMed ID: 30517243
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
19. The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.
Wang YX; Li ML; Yu SG; Liu CM; Han Y; Wang XY
Pathol Res Pract; 2013 Mar; 209(3):151-4. PubMed ID: 23414714
[TBL] [Abstract][Full Text] [Related]
20. The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.
Niu L; Li S; Liang H; Li H
PLoS One; 2015; 10(8):e0135822. PubMed ID: 26275295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
